Efficacy and Safety of Imatinib Mesylate as First-line Treatment for the Patients With Chronic Phase of Chronic Myeloid Leukemia

NCT02317159 · clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
90
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Cttq

Collaborators